mRNA COVID-19 vaccinations are not associated with RVO development 21 days and 12 weeks after vaccination

Case reports have speculated if COVID-19 vaccinations may be associated with retinal vascular occlusions (RVO). Specifically, previous literature speculated an increased risk of RVOs days to weeks after vaccination. After reviewing two recent analyses, mRNA COVID-19 vaccinations do not appear to inc...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:npj vaccines Ročník 9; číslo 1; s. 202 - 2
Hlavní autoři: Shaia, Jacqueline K., Shukla, Priya, Jampol, Lee, Singh, Rishi P.
Médium: Journal Article
Jazyk:angličtina
Vydáno: London Nature Publishing Group UK 28.10.2024
Nature Publishing Group
Nature Portfolio
Témata:
692/699/3161/3175
692/700/478
Biomedical and Life Sciences
Biomedicine
COVID-19
Infectious Diseases
Matters Arising
Medical Microbiology
Public Health
Vaccine
Virology
ISSN:2059-0105, 2059-0105
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Case reports have speculated if COVID-19 vaccinations may be associated with retinal vascular occlusions (RVO). Specifically, previous literature speculated an increased risk of RVOs days to weeks after vaccination. After reviewing two recent analyses, mRNA COVID-19 vaccinations do not appear to increase the risk of RVOs at 3 and 12 weeks post-vaccination. Although both studies had different designs, mRNA vaccines do not appear to influence the risk of RVO development.
Bibliografie:SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
content type line 14
content type line 23
ISSN:2059-0105
2059-0105
DOI:10.1038/s41541-024-00983-0